Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N P Robertson

Showing results (1-10 of 113) with videos related to

Pageof 12
Sort By:
Journal of Neurology|December 15, 2012
Alemtuzumab for multiple sclerosis: a new age of immunotherapyN P Robertson
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 20, 2025
Alemtuzumab: balancing risksN P Robertson
Differentiation; Research in Biological Diversity|January 1, 1979
Incorporation of 35S-sulfate into yolk platelets of Xenopus laevis embryos. A study using electron microscope autoradiographyN P Robertson
Journal of Neurology|April 25, 2012
New and old: notable drug developments for clinical practiceN P Robertson
Journal of Neurology|December 8, 2021
Intravenous immunoglobulin for inflammatory demyelinating polyneuropathyM Talaei, N P Robertson
Journal of Neurology|April 25, 2022
Socioeconomic status in neurological disorders: a modifiable risk factor?J Hrastelj, N P Robertson
Journal of Neurology|July 14, 2022
Clinical patterns in CADASILG Gailani, N P Robertson
Journal of Neurology|August 15, 2014
Reducing central nervous system complications associated with the human immunodeficiency virusD Mclauchlan, N P Robertson
Journal of Neurology|October 22, 2013
Epigenetics of Huntington's diseaseD McLauchlan, N P Robertson
Journal of Neurology|March 27, 2014
Pregnancy and drug use in neurological diseaseM Aguirregomozcorta, N P Robertson
Pageof 12

Showing results (1-10 of 113) with videos related to

Sort By:
Pageof 12
Journal of Neurology|December 15, 2012
Alemtuzumab for multiple sclerosis: a new age of immunotherapyN P Robertson
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 20, 2025
Alemtuzumab: balancing risksN P Robertson
Differentiation; Research in Biological Diversity|January 1, 1979
Incorporation of 35S-sulfate into yolk platelets of Xenopus laevis embryos. A study using electron microscope autoradiographyN P Robertson
Journal of Neurology|April 25, 2012
New and old: notable drug developments for clinical practiceN P Robertson
Journal of Neurology|December 8, 2021
Intravenous immunoglobulin for inflammatory demyelinating polyneuropathyM Talaei, N P Robertson
Journal of Neurology|April 25, 2022
Socioeconomic status in neurological disorders: a modifiable risk factor?J Hrastelj, N P Robertson
Journal of Neurology|July 14, 2022
Clinical patterns in CADASILG Gailani, N P Robertson
Journal of Neurology|August 15, 2014
Reducing central nervous system complications associated with the human immunodeficiency virusD Mclauchlan, N P Robertson
Journal of Neurology|October 22, 2013
Epigenetics of Huntington's diseaseD McLauchlan, N P Robertson
Journal of Neurology|March 27, 2014
Pregnancy and drug use in neurological diseaseM Aguirregomozcorta, N P Robertson
Pageof 12